Articles by Daniel Marsh
Microsoft Rises on Pershing Square Stake; Nvidia Earnings and Yields in Focus
Microsoft shares rose 3% Friday after Pershing Square disclosed a new stake. The market now turns to Nvidia earnings and bond yields for the next catalyst in AI-driven tech stocks.
Tesla Hikes Model Y Prices After Friday Stock Drop
Tesla increased Model Y prices by $500-$1,000 over the weekend, its first such hike in two years, after shares fell 4.75% on Friday to $422.24.
Redwire Soars 27% on Record Backlog and Defense Drone Focus
Redwire shares jumped 27% over five sessions, closing at $14.06, fueled by a record backlog and defense-drone interest, despite a $76.5 million loss.
Ford's Stock Retreats After Energy Storage Rally, Focus Shifts to Orders
Ford shares dropped 7.46% Friday to $13.40, ending a week where the stock surged ~9% on energy storage buzz. Trading volume hit 108.27 million shares.
P&G's 70-Year Dividend Streak Faces Analyst Scrutiny Amid Cost Headwinds
P&G raised its dividend for the 70th consecutive year, but Wall Street remains cautious on cost pressures and tariff risks.
Nu Holdings Shares Slide on Credit Concerns Despite Record Revenue
Nu Holdings shares dropped 5.7% Friday after Q1 results showed credit-loss allowances surging 33% and early delinquencies rising, overshadowing record $5 billion revenue.
Hanmi Financial Stock Declines as Dividend Date Approaches and Regional Banks Retreat
Hanmi Financial shares declined 4.2% last week, more than the broader regional bank index, as rising bond yields and inflation worries pressured the sector. The company's $0.28 dividend is set for payment on May 20.
MeiraGTx Stock Dips 5.5% After Weekly Slide; FDA Designation and Funding in Focus
MeiraGTx shares fell 5.5% Friday to $9.40, ending a 4.3% weekly drop, as the company reported a Q1 net loss of $46.3 million and advanced regulatory filings for key gene therapies.
EPOW Shares Sink Below $1 After Annual Report Raises Going Concern Doubt
E-Power shares closed at $0.66, down 7.04%, after its annual report showed a 28.59% revenue decline and a $26.66 million net loss, raising substantial doubt about its ability to continue.
Korean Investors' US Stock Holdings Break 300 Trillion Won Milestone
Korean investors' US stock holdings have exceeded 300 trillion won, driven by strategic bets on Intel and inverse ETFs amid semiconductor volatility.
ImmunityBio Secures Exclusive US Rights to Japan BCG Strain for Bladder Cancer
ImmunityBio announced exclusive U.S. rights to Japan BCG Laboratory's Tokyo-172 BCG strain for bladder cancer therapy, with FDA discussions planned. Shares closed at $7.97 Friday, down 2.2%.